Stay updated on Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial
Sign up to get notified when there's something new on the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page.

Latest updates to the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page
- Check3 days agoChange DetectedLocations have been added and organized under a unified Locations section, listing sites in Baden-Wurttemberg, Bavaria, Hesse, and Saxony. The previous state-specific location sections were removed, and the page revision updated to v3.3.3.SummaryDifference0.6%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this change does not alter study data, eligibility criteria, or publicly visible details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedDeleted the government funding notice that previously appeared on the page; this banner is not part of the trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedThe screenshots show only minor formatting and layout adjustments to the Study Details page, with no changes to core data such as enrollment, status, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check82 days agoChange DetectedMajor changes: updated operating status notice and version to v3.2.0; removal of v3.1.0.SummaryDifference4%

- Check89 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page.